{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:23:36Z","timestamp":1781299416216,"version":"3.54.1"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T00:00:00Z","timestamp":1091145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1038\/nm1087","type":"journal-article","created":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T17:42:27Z","timestamp":1091209347000},"page":"789-799","source":"Crossref","is-referenced-by-count":3296,"title":["Cancer genes and the pathways they control"],"prefix":"10.1038","volume":"10","author":[{"given":"Bert","family":"Vogelstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W","family":"Kinzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,7,30]]},"reference":[{"key":"BFnm1087_CR1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949\u2013954 (2002).","journal-title":"Nature"},{"key":"BFnm1087_CR2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","volume":"116","author":"PT Wan","year":"2004","unstructured":"Wan, P.T. et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116, 855\u2013867 (2004).","journal-title":"Cell"},{"key":"BFnm1087_CR3","first-page":"105","volume":"1654","author":"M Santarosa","year":"2004","unstructured":"Santarosa, M. & Ashworth, A. Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. Biochim. Biophys. Acta 1654, 105\u2013122 (2004).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnm1087_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ajmg.10320","volume":"111","author":"AG Knudson","year":"2002","unstructured":"Knudson, A.G. Cancer genetics. Am. J. Med. Genet. 111, 96\u2013102 (2002).","journal-title":"Am. J. Med. Genet."},{"key":"BFnm1087_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature01408","volume":"421","author":"EC Friedberg","year":"2003","unstructured":"Friedberg, E.C. DNA damage and repair. Nature 421, 436\u2013440 (2003).","journal-title":"Nature"},{"key":"BFnm1087_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1044-579X(02)00012-3","volume":"12","author":"PC Nowell","year":"2002","unstructured":"Nowell, P.C. Tumor progression: a brief historical perspective. Semin. Cancer Biol. 12, 261\u2013266 (2002).","journal-title":"Semin. Cancer Biol."},{"key":"BFnm1087_CR7","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1158\/0008-5472.CAN-03-3249","volume":"64","author":"CC Maley","year":"2004","unstructured":"Maley, C.C. et al. Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus. Cancer Res. 64, 3414\u20133427 (2004).","journal-title":"Cancer Res."},{"key":"BFnm1087_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0092-8674(02)00621-9","volume":"108","author":"T Van Dyke","year":"2002","unstructured":"Van Dyke, T. & Jacks, T. Cancer modeling in the modern era: progress and challenges. Cell 108, 135\u2013144 (2002).","journal-title":"Cell"},{"key":"BFnm1087_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/cbic.200300614","volume":"4","author":"HR Horvitz","year":"2003","unstructured":"Horvitz, H.R. Worms, life, and death. Chembiochem 4, 697\u2013711 (2003).","journal-title":"Chembiochem"},{"key":"BFnm1087_CR10","first-page":"3689","volume":"60","author":"CJ Sherr","year":"2000","unstructured":"Sherr, C.J. Cancer cell cycles revisited. Cancer Res. 60, 3689\u20133695 (2000).","journal-title":"Cancer Res."},{"key":"BFnm1087_CR11","first-page":"73","volume":"1602","author":"S Ortega","year":"2002","unstructured":"Ortega, S., Malumbres, M. & Barbacid, M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta 1602, 73\u201387 (2002).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnm1087_CR12","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/nrc950","volume":"2","author":"M Classon","year":"2002","unstructured":"Classon, M. & Harlow, E. The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer 2, 910\u2013917 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR13","first-page":"417","volume":"60","author":"K Ichimura","year":"2000","unstructured":"Ichimura, K. et al. Deregulation of the p14ARF\/MDM2\/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res. 60, 417\u2013424 (2000).","journal-title":"Cancer Res."},{"key":"BFnm1087_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein, B., Lane, D. & Levine, A.J. Surfing the p53 network. Nature 408, 307\u2013310 (2000).","journal-title":"Nature"},{"key":"BFnm1087_CR15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/sj.cdd.4401183","volume":"10","author":"M Oren","year":"2003","unstructured":"Oren, M. Decision making by p53: life, death and cancer. Cell Death Differ. 10, 431\u2013442 (2003).","journal-title":"Cell Death Differ."},{"key":"BFnm1087_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3","volume":"187","author":"C Prives","year":"1999","unstructured":"Prives, C. & Hall, P.A. The p53 pathway. J. Pathol. 187, 112\u2013126 (1999).","journal-title":"J. Pathol."},{"key":"BFnm1087_CR17","doi-asserted-by":"publisher","first-page":"d268","DOI":"10.2741\/A726","volume":"7","author":"G Klein","year":"2002","unstructured":"Klein, G. Perspectives in studies of human tumor viruses. Front. Biosci. 7, d268\u2013d274 (2002).","journal-title":"Front. Biosci."},{"key":"BFnm1087_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0168-1702(02)00190-9","volume":"89","author":"K Munger","year":"2002","unstructured":"Munger, K. & Howley, P.M. Human papillomavirus immortalization and transformation functions. Virus Res. 89, 213\u2013228 (2002).","journal-title":"Virus Res."},{"key":"BFnm1087_CR19","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1038\/sj.onc.1204958","volume":"20","author":"H zur Hausen","year":"2001","unstructured":"zur Hausen, H. Oncogenic DNA viruses. Oncogene 20, 7820\u20137823 (2001).","journal-title":"Oncogene"},{"key":"BFnm1087_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0092-8674(00)81688-8","volume":"100","author":"T Hunter","year":"2000","unstructured":"Hunter, T. Signaling\u20132000 and beyond. Cell 100, 113\u2013127 (2000).","journal-title":"Cell"},{"key":"BFnm1087_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0022-5193(03)00120-6","volume":"223","author":"NL Komarova","year":"2003","unstructured":"Komarova, N.L., Sengupta, A. & Nowak, M.A. Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability. J. Theor. Biol. 223, 433\u2013450 (2003).","journal-title":"J. Theor. Biol."},{"key":"BFnm1087_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.genet.32.1.495","volume":"32","author":"JD Rowley","year":"1998","unstructured":"Rowley, J.D. The critical role of chromosome translocations in human leukemias. Annu. Rev. Genet. 32, 495\u2013519 (1998).","journal-title":"Annu. Rev. Genet."},{"key":"BFnm1087_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1383-5742(00)00006-5","volume":"462","author":"F Mitelman","year":"2000","unstructured":"Mitelman, F. Recurrent chromosome aberrations in cancer. Mutat. Res. 462, 247\u2013253 (2000).","journal-title":"Mutat. Res."},{"key":"BFnm1087_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/path.1473","volume":"202","author":"HM Verheul","year":"2004","unstructured":"Verheul, H.M., Voest, E.E. & Schlingemann, R.O. Are tumours angiogenesis-dependent? J. Pathol. 202, 5\u201313 (2004).","journal-title":"J. Pathol."},{"key":"BFnm1087_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0959-437X(00)00156-8","volume":"11","author":"TD Tlsty","year":"2001","unstructured":"Tlsty, T.D. & Hein, P.W. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr. Opin. Genet. Dev. 11, 54\u201359 (2001).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFnm1087_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr634","volume":"6","author":"JE Fata","year":"2004","unstructured":"Fata, J.E., Werb, Z. & Bissell, M.J. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res. 6, 1\u201311 (2004).","journal-title":"Breast Cancer Res."},{"key":"BFnm1087_CR27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrc905","volume":"2","author":"R Kerbel","year":"2002","unstructured":"Kerbel, R. & Folkman, J. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2, 727\u2013739 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/sonc.2002.37263","volume":"29","author":"J Folkman","year":"2002","unstructured":"Folkman, J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29, 15\u201318 (2002).","journal-title":"Semin. Oncol."},{"key":"BFnm1087_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrd1381","volume":"3","author":"N Ferrara","year":"2004","unstructured":"Ferrara, N., Hillan, K.J., Gerber, H.P. & Novotny, W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat. Rev. Drug Discov. 3, 391\u2013400 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm1087_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","volume":"1","author":"K Kondo","year":"2002","unstructured":"Kondo, K., Klco, J., Nakamura, E., Lechpammer, M. & Kaelin, W.G. Jr. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 1, 237\u2013246 (2002).","journal-title":"Cancer Cell"},{"key":"BFnm1087_CR31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza, G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721\u2013732 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrg1085","volume":"4","author":"RL Strausberg","year":"2003","unstructured":"Strausberg, R.L., Simpson, A.J. & Wooster, R. Sequence-based cancer genomics: progress, lessons and opportunities. Nat. Rev. Genet. 4, 409\u2013418 (2003).","journal-title":"Nat. Rev. Genet."},{"key":"BFnm1087_CR33","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1073\/pnas.0334858100","volume":"100","author":"LA Loeb","year":"2003","unstructured":"Loeb, L.A., Loeb, K.R. & Anderson, J.P. Multiple mutations and cancer. Proc. Natl. Acad. Sci. USA 100, 776\u2013781 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1087_CR34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrc1165","volume":"3","author":"H Rajagopalan","year":"2003","unstructured":"Rajagopalan, H., Nowak, M.A., Vogelstein, B. & Lengauer, C. The significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer 3, 695\u2013701 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc1170","volume":"3","author":"OM Sieber","year":"2003","unstructured":"Sieber, O.M., Heinimann, K. & Tomlinson, I.P. Genomic instability\u2014the engine of tumorigenesis? Nat. Rev. Cancer 3, 701\u2013708 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR36","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1073\/pnas.261714699","volume":"99","author":"TL Wang","year":"2002","unstructured":"Wang, T.L. et al. Prevalence of somatic alterations in the colorectal cancer cell genome. Proc. Natl. Acad. Sci. USA 99, 3076\u20133080 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1087_CR37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/25292","volume":"396","author":"C Lengauer","year":"1998","unstructured":"Lengauer, C., Kinzler, K.W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643\u2013649 (1998).","journal-title":"Nature"},{"key":"BFnm1087_CR38","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4161\/cc.2.3.382","volume":"2","author":"P Duesberg","year":"2003","unstructured":"Duesberg, P. & Li, R. Multistep carcinogenesis: a chain reaction of aneuploidizations. Cell Cycle 2, 202\u2013210 (2003).","journal-title":"Cell Cycle"},{"key":"BFnm1087_CR39","doi-asserted-by":"publisher","first-page":"R145","DOI":"10.1093\/hmg\/ddg261","volume":"12","author":"DG Albertson","year":"2003","unstructured":"Albertson, D.G. & Pinkel, D. Genomic microarrays in human genetic disease and cancer. Hum. Mol. Genet. 12 (spec. no. 2), R145\u2013R152 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1087_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0065-230X(01)83007-4","volume":"83","author":"Y Shiloh","year":"2001","unstructured":"Shiloh, Y. & Kastan, M.B. ATM: genome stability, neuronal development, and cancer cross paths. Adv. Cancer Res. 83, 209\u2013254 (2001).","journal-title":"Adv. Cancer Res."},{"key":"BFnm1087_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/35044000","volume":"408","author":"R Scully","year":"2000","unstructured":"Scully, R. & Livingston, D.M. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408, 429\u2013432 (2000).","journal-title":"Nature"},{"key":"BFnm1087_CR42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1126\/science.297.5581.565","volume":"297","author":"RS Maser","year":"2002","unstructured":"Maser, R.S. & DePinho, R.A. Connecting chromosomes, crisis, and cancer. Science 297, 565\u2013569 (2002).","journal-title":"Science"},{"key":"BFnm1087_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1535-6108(03)00195-8","volume":"4","author":"G Pihan","year":"2003","unstructured":"Pihan, G. & Doxsey, S.J. Mutations and aneuploidy: co-conspirators in cancer? Cancer Cell 4, 89\u201394 (2003).","journal-title":"Cancer Cell"},{"key":"BFnm1087_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nature02313","volume":"428","author":"H Rajagopalan","year":"2004","unstructured":"Rajagopalan, H. et al. Inactivation of hCDC4 can cause chromosomal instability. Nature 428, 77\u201381 (2004).","journal-title":"Nature"},{"key":"BFnm1087_CR45","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1038\/sj.onc.1207518","volume":"23","author":"JW Shay","year":"2004","unstructured":"Shay, J.W. & Roninson, I.B. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23, 2919\u20132933 (2004).","journal-title":"Oncogene"},{"key":"BFnm1087_CR46","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc865","volume":"2","author":"AF Chambers","year":"2002","unstructured":"Chambers, A.F., Groom, A.C. & MacDonald, I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563\u2013572 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/scbi.2001.0416","volume":"12","author":"IJ Fidler","year":"2002","unstructured":"Fidler, I.J. Critical determinants of metastasis. Semin. Cancer Biol. 12, 89\u201396 (2002).","journal-title":"Semin. Cancer Biol."},{"key":"BFnm1087_CR48","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/sj.bjc.6601590","volume":"90","author":"KW Hunter","year":"2004","unstructured":"Hunter, K.W. Host genetics and tumour metastasis. Br. J. Cancer 90, 752\u2013755 (2004).","journal-title":"Br. J. Cancer"},{"key":"BFnm1087_CR49","first-page":"2969","volume":"6","author":"RH Hruban","year":"2000","unstructured":"Hruban, R.H., Goggins, M., Parsons, J. & Kern, S.E. Progression model for pancreatic cancer. Clin. Cancer Res. 6, 2969\u20132972 (2000).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1087_CR50","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1101\/gad.1158703","volume":"17","author":"AJ Aguirre","year":"2003","unstructured":"Aguirre, A.J. et al. Activated Kras and Ink4a\/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 17, 3112\u20133126 (2003).","journal-title":"Genes Dev."},{"key":"BFnm1087_CR51","first-page":"5523","volume":"54","author":"J Jen","year":"1994","unstructured":"Jen, J. et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 54, 5523\u20135526 (1994).","journal-title":"Cancer Res."},{"key":"BFnm1087_CR52","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/0016-5085(95)90092-6","volume":"108","author":"TP Pretlow","year":"1995","unstructured":"Pretlow, T.P. Aberrant crypt foci and K-ras mutations: earliest recognized players or innocent bystanders in colon carcinogenesis? Gastroenterology 108, 600\u2013603 (1995).","journal-title":"Gastroenterology"},{"key":"BFnm1087_CR53","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/path.1521","volume":"202","author":"NL Sieben","year":"2004","unstructured":"Sieben, N.L. et al. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours. J. Pathol. 202, 336\u2013340 (2004).","journal-title":"J. Pathol."},{"key":"BFnm1087_CR54","first-page":"565","volume-title":"The Genetic Basis of Human Cancer","author":"KW Kinzler","year":"1998","unstructured":"Kinzler, K.W. & Vogelstein, B. Colorectal Tumors. in The Genetic Basis of Human Cancer (eds. Vogelstein, B. & Kinzler, K.W.) 565\u2013587 (McGraw-Hill, New York, 1998)."},{"key":"BFnm1087_CR55","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1146\/annurev.bi.56.070187.004023","volume":"56","author":"M Barbacid","year":"1987","unstructured":"Barbacid, M. ras genes. Annu. Rev. Biochem. 56, 779\u2013827 (1987).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnm1087_CR56","first-page":"4682","volume":"49","author":"JL Bos","year":"1989","unstructured":"Bos, J.L. ras oncogenes in human cancer: a review. Cancer Res. 49, 4682\u20134689 (1989).","journal-title":"Cancer Res."},{"key":"BFnm1087_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng721","volume":"29","author":"Z Zhang","year":"2001","unstructured":"Zhang, Z. et al. Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat. Genet. 29, 25\u201333 (2001).","journal-title":"Nat. Genet."},{"key":"BFnm1087_CR58","first-page":"4514","volume":"62","author":"R Diaz","year":"2002","unstructured":"Diaz, R. et al. The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res. 62, 4514\u20134518 (2002).","journal-title":"Cancer Res."},{"key":"BFnm1087_CR59","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1126\/science.1094732","volume":"303","author":"M Bronner-Fraser","year":"2004","unstructured":"Bronner-Fraser, M. Development. Making sense of the sensory lineage. Science 303, 966\u2013968 (2004).","journal-title":"Science"},{"key":"BFnm1087_CR60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0921-8777(98)00056-1","volume":"409","author":"J Jiricny","year":"1998","unstructured":"Jiricny, J. Eukaryotic mismatch repair: an update. Mutat. Res. 409, 107\u2013121 (1998).","journal-title":"Mutat. Res."},{"key":"BFnm1087_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0959-437X(97)80117-7","volume":"7","author":"R Fishel","year":"1997","unstructured":"Fishel, R. & Wilson, T. MutS homologs in mammalian cells. Curr. Opin. Genet. Dev. 7, 105\u2013113 (1997).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFnm1087_CR62","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMra012242","volume":"348","author":"HT Lynch","year":"2003","unstructured":"Lynch, H.T. & de la Chapelle, A. Hereditary colorectal cancer. N. Engl. J. Med. 348, 919\u2013932 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1087_CR63","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s005350200015","volume":"37","author":"H Yamamoto","year":"2002","unstructured":"Yamamoto, H., Imai, K. & Perucho, M. Gastrointestinal cancer of the microsatellite mutator phenotype pathway. J. Gastroenterol. 37, 153\u2013163 (2002).","journal-title":"J. Gastroenterol."},{"key":"BFnm1087_CR64","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/1043-4682(95)90014-4","volume":"6","author":"R Honchel","year":"1995","unstructured":"Honchel, R., Halling, K.C. & Thibodeau, S.N. Genomic instability in neoplasia. Semin. Cell Biol. 6, 45\u201352 (1995).","journal-title":"Semin. Cell Biol."},{"key":"BFnm1087_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/4462","volume":"21","author":"PO Brown","year":"1999","unstructured":"Brown, P.O. & Botstein, D. Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21, 33\u201337 (1999).","journal-title":"Nat. Genet."},{"key":"BFnm1087_CR66","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1200\/JCO.2001.19.11.2948","volume":"19","author":"K Polyak","year":"2001","unstructured":"Polyak, K. & Riggins, G.J. Gene discovery using the serial analysis of gene expression technique: implications for cancer research. J. Clin. Oncol. 19, 2948\u20132958 (2001).","journal-title":"J. Clin. Oncol."},{"key":"BFnm1087_CR67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"3","author":"PA Jones","year":"2002","unstructured":"Jones, P.A. & Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415\u2013428 (2002).","journal-title":"Nat. Rev. Genet."},{"key":"BFnm1087_CR68","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrc1279","volume":"4","author":"AP Feinberg","year":"2004","unstructured":"Feinberg, A.P. & Tycko, B. The history of cancer epigenetics. Nat. Rev. Cancer 4, 143\u2013153 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR69","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nature01626","volume":"422","author":"FS Collins","year":"2003","unstructured":"Collins, F.S., Green, E.D., Guttmacher, A.E. & Guyer, M.S. A vision for the future of genomics research. Nature 422, 835\u2013847 (2003).","journal-title":"Nature"},{"key":"BFnm1087_CR70","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1042\/bst0310437","volume":"31","author":"EE Schadt","year":"2003","unstructured":"Schadt, E.E., Monks, S.A. & Friend, S.H. A new paradigm for drug discovery: integrating clinical, genetic, genomic and molecular phenotype data to identify drug targets. Biochem. Soc. Trans. 31, 437\u2013443 (2003).","journal-title":"Biochem. Soc. Trans."},{"key":"BFnm1087_CR71","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature02370","volume":"428","author":"PJ Paddison","year":"2004","unstructured":"Paddison, P.J. et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 428, 427\u2013431 (2004).","journal-title":"Nature"},{"key":"BFnm1087_CR72","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature02371","volume":"428","author":"K Berns","year":"2004","unstructured":"Berns, K. et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428, 431\u2013437 (2004).","journal-title":"Nature"},{"key":"BFnm1087_CR73","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.med.55.091902.105237","volume":"55","author":"KP Rosenblatt","year":"2004","unstructured":"Rosenblatt, K.P. et al. Serum proteomics in cancer diagnosis and management. Annu. Rev. Med. 55, 97\u2013112 (2004).","journal-title":"Annu. Rev. Med."},{"key":"BFnm1087_CR74","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1081\/CNV-120025096","volume":"21","author":"J Luo","year":"2003","unstructured":"Luo, J., Isaacs, W.B., Trent, J.M. & Duggan, D.J. Looking beyond morphology: cancer gene expression profiling using DNA microarrays. Cancer Invest. 21, 937\u2013949 (2003).","journal-title":"Cancer Invest."},{"key":"BFnm1087_CR75","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ccr.2004.05.015","volume":"5","author":"XJ Ma","year":"2004","unstructured":"Ma, X.J. et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5, 607\u2013616 (2004).","journal-title":"Cancer Cell"},{"key":"BFnm1087_CR76","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrc1299","volume":"4","author":"PA Futreal","year":"2004","unstructured":"Futreal, P.A. et al. A census of human cancer genes. Nat. Rev. Cancer 4, 177\u2013183 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR77","doi-asserted-by":"publisher","first-page":"8715","DOI":"10.1073\/pnas.0400027101","volume":"101","author":"BG Masayesva","year":"2004","unstructured":"Masayesva, B.G. et al. Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression. Proc. Natl. Acad. Sci. USA 101, 8715\u20138720 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1087_CR78","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/sj.onc.1205062","volume":"21","author":"SA Stewart","year":"2002","unstructured":"Stewart, S.A. & Weinberg, R.A. Senescence: does it all happen at the ends? Oncogene 21, 627\u2013630 (2002).","journal-title":"Oncogene"},{"key":"BFnm1087_CR79","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrc1142","volume":"3","author":"DM Feldser","year":"2003","unstructured":"Feldser, D.M., Hackett, J.A. & Greider, C.W. Telomere dysfunction and the initiation of genome instability. Nat. Rev. Cancer 3, 623\u2013627 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR80","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1098\/rstb.2003.1370","volume":"359","author":"SR Chan","year":"2004","unstructured":"Chan, S.R. & Blackburn, E.H. Telomeres and telomerase. Phil. Trans. R. Soc. Lond. B 359, 109\u2013121 (2004).","journal-title":"Phil. Trans. R. Soc. Lond. B"},{"key":"BFnm1087_CR81","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0092-8674(04)00038-8","volume":"116","author":"TR Cech","year":"2004","unstructured":"Cech, T.R. Beginning to understand the end of the chromosome. Cell 116, 273\u2013279 (2004).","journal-title":"Cell"},{"key":"BFnm1087_CR82","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nbt965","volume":"22","author":"GL Miklos","year":"2004","unstructured":"Miklos, G.L. & Maleszka, R. Microarray reality checks in the context of a complex disease. Nat. Biotechnol. 22, 615\u2013621 (2004).","journal-title":"Nat. Biotechnol."},{"key":"BFnm1087_CR83","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.arcmed.2003.08.007","volume":"34","author":"KJ Hope","year":"2003","unstructured":"Hope, K.J., Jin, L. & Dick, J.E. Human acute myeloid leukemia stem cells. Arch. Med. Res. 34, 507\u2013514 (2003).","journal-title":"Arch. Med. Res."},{"key":"BFnm1087_CR84","first-page":"669","volume":"16","author":"C Berking","year":"2001","unstructured":"Berking, C. & Herlyn, M. Human skin reconstruct models: a new application for studies of melanocyte and melanoma biology. Histol. Histopathol. 16, 669\u2013674 (2001).","journal-title":"Histol. Histopathol."},{"key":"BFnm1087_CR85","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1073\/pnas.0401064101","volume":"101","author":"C Kuperwasser","year":"2004","unstructured":"Kuperwasser, C. et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl Acad. Sci. USA 101, 4966\u20134971 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnm1087_CR86","first-page":"669","volume-title":"Cancer Medicine","author":"EI Frei","year":"2003","unstructured":"Frei, E.I. & Eder, J.P. Principles of dose, schedule, and combination Therapy. in Cancer Medicine (eds. Kufe, D.W. et al.) 669\u2013677 (B.C. Decker, Inc., Hamilton, Ontario, 2003)."},{"key":"BFnm1087_CR87","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4757-3147-7_4","volume":"103","author":"MD Pegram","year":"2000","unstructured":"Pegram, M.D., Konecny, G. & Slamon, D.J. The molecular and cellular biology of HER2\/neu gene amplification\/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer. Cancer Treat. Res. 103, 57\u201375 (2000).","journal-title":"Cancer Treat. Res."},{"key":"BFnm1087_CR88","first-page":"87","volume-title":"Hematology 2001","author":"BJ Druker","year":"2001","unstructured":"Druker, B.J. et al. Chronic myelogenous leukemia. in Hematology 2001 (American Society of Hematology Education Program) 87\u2013112 (American Society of Hematology, 2001)."},{"key":"BFnm1087_CR89","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00428-003-0945-5","volume":"444","author":"G Mechtersheimer","year":"2004","unstructured":"Mechtersheimer, G. et al. Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib. Virchows Arch. 444, 108\u2013118 (2004).","journal-title":"Virchows Arch."},{"key":"BFnm1087_CR90","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.ijrobp.2003.09.099","volume":"58","author":"CJ Langer","year":"2004","unstructured":"Langer, C.J. Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: focus on NSCLC. Int. J. Radiat. Oncol. Biol. Phys. 58, 991\u20131002 (2004).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnm1087_CR91","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1081\/CNV-120027585","volume":"22","author":"A Duensing","year":"2004","unstructured":"Duensing, A., Heinrich, M.C., Fletcher, C.D. & Fletcher, J.A. Biology of gastrointestinal stromal tumors: KIT mutations and beyond. Cancer Invest. 22, 106\u2013116 (2004).","journal-title":"Cancer Invest."},{"key":"BFnm1087_CR92","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez, J.G. et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304, 1497\u20131500 (2004).","journal-title":"Science"},{"key":"BFnm1087_CR93","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch, T.J. et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350, 2129\u20132139 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1087_CR94","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<127::AID-PATH251>3.0.CO;2-T","volume":"187","author":"CA Schmitt","year":"1999","unstructured":"Schmitt, C.A. & Lowe, S.W. Apoptosis and therapy. J. Pathol. 187, 127\u2013137 (1999).","journal-title":"J. Pathol."},{"key":"BFnm1087_CR95","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","volume":"116","author":"NN Danial","year":"2004","unstructured":"Danial, N.N. & Korsmeyer, S.J. Cell death: critical control points. Cell 116, 205\u2013219 (2004).","journal-title":"Cell"},{"key":"BFnm1087_CR96","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1054\/drup.2001.0193","volume":"4","author":"JM Brown","year":"2001","unstructured":"Brown, J.M. & Wouters, B.G. Apoptosis: mediator or mode of cell killing by anticancer agents? Drug Resist. Updat. 4, 135\u2013136 (2001).","journal-title":"Drug Resist. Updat."},{"key":"BFnm1087_CR97","first-page":"2696","volume":"3","author":"IB Weinstein","year":"1997","unstructured":"Weinstein, I.B. et al. Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. Clin. Cancer Res. 3, 2696\u20132702 (1997).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1087_CR98","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.1365-2796.2003.01098.x","volume":"253","author":"P Nygren","year":"2003","unstructured":"Nygren, P. & Larsson, R. Overview of the clinical efficacy of investigational anticancer drugs. J. Intern. Med. 253, 46\u201375 (2003).","journal-title":"J. Intern. Med."},{"key":"BFnm1087_CR99","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1158\/1078-0432.CCR-0835-03","volume":"10","author":"LY Shih","year":"2004","unstructured":"Shih, L.Y. et al. Heterogeneous patterns of FLT3 Asp(835) mutations in relapsed de novo acute myeloid leukemia: a comparative analysis of 120 paired diagnostic and relapse bone marrow samples. Clin. Cancer Res. 10, 1326\u20131332 (2004).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1087_CR100","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0092-8674(00)81333-1","volume":"87","author":"KW Kinzler","year":"1996","unstructured":"Kinzler, K.W. & Vogelstein, B. Lessons from hereditary colon cancer. Cell 87, 159\u2013170 (1996).","journal-title":"Cell"},{"key":"BFnm1087_CR101","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nm0103-123","volume":"9","author":"R Weissleder","year":"2003","unstructured":"Weissleder, R. & Ntziachristos, V. Shedding light onto live molecular targets. Nat. Med. 9, 123\u2013128 (2003).","journal-title":"Nat. Med."},{"key":"BFnm1087_CR102","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nrc755","volume":"2","author":"D Sidransky","year":"2002","unstructured":"Sidransky, D. Emerging molecular markers of cancer. Nat. Rev. Cancer 2, 210\u2013219 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR103","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc1360","volume":"4","author":"A Gschwind","year":"2004","unstructured":"Gschwind, A., Fischer, O.M. & Ullrich, A. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer 4, 361\u2013370 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR104","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc969","volume":"3","author":"J Downward","year":"2003","unstructured":"Downward, J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11\u201322 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR105","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/35106065","volume":"1","author":"M Malumbres","year":"2001","unstructured":"Malumbres, M. & Barbacid, M. To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 1, 222\u2013231 (2001).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR106","first-page":"1","volume":"1653","author":"RH Giles","year":"2003","unstructured":"Giles, R.H., van Es, J.H. & Clevers, H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653, 1\u201324 (2003).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnm1087_CR107","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"LC Cantley","year":"2002","unstructured":"Cantley, L.C. The phosphoinositide 3-kinase pathway. Science 296, 1655\u20131657 (2002).","journal-title":"Science"},{"key":"BFnm1087_CR108","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi, Y. & Massague, J. Mechanisms of TGF-\u03b2 signaling from cell membrane to the nucleus. Cell 113, 685\u2013700 (2003).","journal-title":"Cell"},{"key":"BFnm1087_CR109","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0304-3835(03)00451-8","volume":"204","author":"A Ruiz i Altaba","year":"2004","unstructured":"Ruiz i Altaba. A., Stecca, B. & Sanchez, P. Hedgehog\u2013Gli signaling in brain tumors: stem cells and paradevelopmental programs in cancer. Cancer Lett. 204, 145\u2013157 (2004).","journal-title":"Cancer Lett."},{"key":"BFnm1087_CR110","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1101\/gad.1126903","volume":"17","author":"JM Adams","year":"2003","unstructured":"Adams, J.M. Ways of dying: multiple pathways to apoptosis. Genes Dev. 17, 2481\u20132495 (2003).","journal-title":"Genes Dev."},{"key":"BFnm1087_CR111","first-page":"103","volume":"1","author":"MV Blagosklonny","year":"2002","unstructured":"Blagosklonny, M.V. & Pardee, A.B. The restriction point of the cell cycle. Cell Cycle 1, 103\u2013110 (2002).","journal-title":"Cell Cycle"},{"key":"BFnm1087_CR112","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1043-2760(01)00528-8","volume":"13","author":"DR Plas","year":"2002","unstructured":"Plas, D.R. & Thompson, C.B. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol. Metab. 13, 75\u201378 (2002).","journal-title":"Trends Endocrinol. Metab."},{"key":"BFnm1087_CR113","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1535-6108(02)00024-7","volume":"1","author":"DR Green","year":"2002","unstructured":"Green, D.R. & Evan, G.I. A matter of life and death. Cancer Cell 1, 19\u201330 (2002).","journal-title":"Cancer Cell"},{"key":"BFnm1087_CR114","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrc1013","volume":"3","author":"C Eng","year":"2003","unstructured":"Eng, C., Kiuru, M., Fernandez, M.J. & Aaltonen, L.A. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat. Rev. Cancer 3, 193\u2013202 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnm1087_CR115","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1126\/science.1098020","volume":"304","author":"L Lum","year":"2004","unstructured":"Lum, L. & Beachy, P.A. The Hedgehog response network: sensors, switches, and routers. Science 304, 1755\u20131759 (2004).","journal-title":"Science"},{"key":"BFnm1087_CR116","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1126\/science.1066355","volume":"295","author":"AH Brivanlou","year":"2002","unstructured":"Brivanlou, A.H. & Darnell, J.E. Jr. Signal transduction and the control of gene expression. Science 295, 813\u2013818 (2002).","journal-title":"Science"},{"key":"BFnm1087_CR117","volume-title":"The Genetic Basis of Human Cancer","author":"B Vogelstein","year":"2002","unstructured":"Vogelstein, B. & Kinzler, K.W. The Genetic Basis of Human Cancer (McGraw-Hill, Toronto, 2002)."},{"key":"BFnm1087_CR118","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1038\/sj.onc.1207130","volume":"23","author":"ER Cameron","year":"2004","unstructured":"Cameron, E.R. & Neil, J.C. The Runx genes: lineage-specific oncogenes and tumor suppressors. Oncogene 23, 4308\u20134314 (2004).","journal-title":"Oncogene"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1087","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:02:59Z","timestamp":1684447379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,30]]},"references-count":118,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["BFnm1087"],"URL":"https:\/\/doi.org\/10.1038\/nm1087","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,30]]}}}